Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials

由 Xing, Baodi, Zhao, Yuhang, Dong, Bingzi, Zhou, Yue, Lv, Wenshan, Zhao, Wenjuan
發表在 J Diabetes Investig (2020)